7th Jul 2023 18:34
Ondine Biomedical Inc - Vancouver-based life sciences company specialising in photodisinfection therapies - Says it has modified its Phase Three Clinical Trial Design for its lead product, Steriwave, to cover a broader range of hospital-acquired infections, including surgical site infections, bloodstream infections and pneumonias. The broadening of the design is not expected to have any impact on the recruitment rate into the trial. Read More